Aminas

5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine is a monoclonal antibody that blocks the signal of CTLA-4, a receptor on T cells. It has been shown to be effective in inhibiting skin cancer and primary breast cancers. This drug also has immunomodulatory effects and can be used to treat autoimmune diseases. 5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine binds to ctla-4 with high affinity and specificity, preventing the interaction of ctla-4 with its ligands such as CD80 (B7.1) and CD86 (B7.2). This prevents the activation of T cells by antigen presenting cells and suppresses the immune response.

Please enquire for more information about 2-Amino-1-(2,3-dihydro-benzofuran-5-yl)-ethanolHydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 3-Amino-6,7-dimethoxy-2-methylquinazolin-4(3H)-one including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 2-Phenylpropan-1-amine hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 4-Chlorophenyl 2-aminobenzoate including the price, delivery time and more detailed product information at the technical inquiry form on this page

Tetrabutylammonium hexafluorophosphate is a chemical reagent that is used in organic synthesis. It is a strong Lewis acid that reacts with substrates to form adducts. Tetrabutylammonium hexafluorophosphate reacts with trifluoroacetic acid, ethylene diamine, and hydrogen fluoride to produce the salt tetrabutylammonium hexafluorophosphate dihydrate (TBAPF). The reaction proceeds through an ionic intermediate that involves the abstraction of a proton from the substrate by the tetrabutylammonium cation followed by nucleophilic attack on the anion by water. Tetrabutylammonium hexafluorophosphate dihydrate can be formed via this mechanism as well as through a simple salt metathesis reaction between TBAPF and sodium carbonate. This reagent has been shown to form crystals of good quality for

Racemic benzodioxole-5-butanamine hydrochloride (RAC) is a pharmacologic agent that has been shown to bind to dopamine receptors, thereby activating them. It has been shown to be an effective treatment for depression and other mental illnesses. Racemic benzodioxole-5-butanamine hydrochloride is also used in analytical toxicology as a chromatographic standard. This compound has been synthesized using the asymmetric synthesis of primary amines. RAC is also an enantiomer and can exist in two forms: (+)-RAC and (-)-RAC, which are mirror images of each other. The (+) form of racemic benzodioxole-5-butanamine hydrochloride is the more active form, with greater binding affinity for dopamine receptors than the (-) form.

Please enquire for more information about 3-{[(3,4-Dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

Indene-1-methanamine is a drug that has been used for the treatment of neurologic disorders and is an ester of aliphatic hydrocarbons. It has been shown to have antidepressant effects in animal models, which may be due to its ability to bind to 5-HT1A receptors. Indene-1-methanamine also has antimicrobial properties and can be used for treating bladder infections as well as cancer. This drug binds to the quinolizine site on bacterial DNA gyrase, which inhibits DNA synthesis and leads to cell death.

3-(1-Naphthyl)propyl]amine is an organic compound that is a colorless solid with a melting point of -118°C. It is soluble in water, methanol, and acetone. 3-(1-Naphthyl)propyl]amine forms acid when heated with concentrated hydrochloric acid. The reaction produces hydrogen chloride gas and benzoic acid as a byproduct. 3-(1-Naphthyl)propyl]amine also reacts with pyridine to produce carbamic acid and ammonia gas as a byproduct. This can be rationalized systematically by the loss of the amine group from the nitrogen atom of the amine molecule. Carbamic acid has two acidic protons on it which are stabilized by the carbonyl group on the other side of the molecule. 3-(1-Naphthyl)propyl]amine can also react with anions such as carbonate ions to form carbamate salts,

Please enquire for more information about 2-(tert-Butylamino)-4,6-dichloro-1,3,5-triazine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about cis-Dichloro(N,N,N',N'-tetramethylethylenediamine)palladium(II) including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 2-[(Dimethylamino)methylene]-5-(2,3,4-trimethoxyphenyl)cyclohexane-1,3-dione including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-Amino-4-chloro-3-nitropyridine is a potent inhibitory molecule that inhibits the activity of the enzyme acetylcholinesterase. It has been used in the treatment of chronic pain, and has been shown to be effective for inhibiting malonate esters and amino acid esters. This drug is an ethyl ester that can be synthesized from chlorobenzene and malonic acid by chlorinating it with chlorine gas. 2-Amino-4-chloro-3-nitropyridine has also been shown to have a high affinity for malonic acid diethyl esters.

Please enquire for more information about N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine including the price, delivery time and more detailed product information at the technical inquiry form on this page

4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine is a monoclonal antibody that binds to cancer cells. It has been shown to be effective in the treatment of leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma. The binding of 4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine to cancer cells is due to the formation of a coordination geometry between the copper complex and the nitrogen atoms on the amino group. This drug has been shown to inhibit tumor growth by blocking the synthesis of DNA and RNA, which are key components in cell division. 4AADNP also inhibits cancer cells' ability to uptake glucose by inhibiting cellular glucose transporters. The binding affinity of 4AADNP for cancer cells is higher than for normal cells because cancer cells have more receptors for this drug

Please enquire for more information about 3-Chloro-N-methylpropan-1-amine HCl including the price, delivery time and more detailed product information at the technical inquiry form on this page

3-Hydroxy-4-amino-butyric acid is a synthetase that catalyzes the formation of 3-hydroxy-4 amino butyric acid from 3-hydroxy butyric acid and ammonia. This reaction occurs in the presence of chloride ions, ethyl bromoacetate and butyric acid. The isolated yield of this reaction is 47%. The product can be converted to 3-amino butyric acid by dehydrating it with hydrochloric acid. 3-Hydroxy-4 amino butyric acid has been shown to have anticancer properties in vitro. It also has been shown to have antiinflammatory properties, which may be due to its ability to inhibit the production of prostaglandin E2, an inflammatory mediator.